Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
98M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
5.76M
-
Shares change
-
-205K
-
Total reported value, excl. options
-
$22.4M
-
Value change
-
-$373K
-
Number of buys
-
9
-
Number of sells
-
-10
-
Price
-
$3.88
Significant Holders of aTYR PHARMA INC - COMMON STOCK (ATYR) as of Q4 2020
24 filings reported holding ATYR - aTYR PHARMA INC - COMMON STOCK as of Q4 2020.
aTYR PHARMA INC - COMMON STOCK (ATYR) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.76M shares
of 98M outstanding shares and own 5.88% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (1.62M shares), FMR LLC (1.53M shares), Alyeska Investment Group, L.P. (843K shares), Ikarian Capital, LLC (400K shares), Altium Capital Management LP (332K shares), RENAISSANCE TECHNOLOGIES LLC (319K shares), VANGUARD GROUP INC (250K shares), TWO SIGMA ADVISERS, LP (85K shares), ACADIAN ASSET MANAGEMENT LLC (83.1K shares), and GEODE CAPITAL MANAGEMENT, LLC (48.6K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.